EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells
- 23 July 2008
- journal article
- review article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 68 (2), 163-168
- https://doi.org/10.1136/ard.2008.091918
Abstract
Systemic sclerosis (SSc) is characterised by a progressive microangiopathy that contributes significantly to the morbidity of patients with SSc. Besides insufficient angiogenesis, defective vasculogenesis with altered numbers of endothelial precursor cells (EPCs) might also contribute to the vascular pathogenesis of SSc. However, different protocols for isolation, enrichment, culture and quantification of EPCs are currently used, which complicate comparison and interpretation of the results from different studies. The aim of the European League Against Rheumatism Scleroderma Trials and Research (EUSTAR) group expert panel was to provide recommendations for standardisation of future research on EPCs. Consensus statements and recommendations were developed in a face to face meeting by an expert panel of the basic science working group of EUSTAR. The findings were: cardiovascular risk factors and medications such as statins should be described in detail. A detailed description of methods considering isolation, culture, enrichment and detection of EPCs should be given. For in vitro culture of EPCs, no protocol has been shown to be superior to another, but coating with laminin and type IV collagen would resemble most closely the situation in vivo. The endothelial phenotype should be confirmed in all in vitro cultures at the end of the culture period. We recommend using CD133, vascular endothelial growth factor type 2 receptor (VEGFR2) and CD34 in combination with a viability marker for quantification of EPCs in the blood. Finally, exact standard operating procedures for fluorescence-activated cell sorting (FACS) analysis are given that should be strictly followed. In summary, the EUSTAR recommendations will help to unify EPC research and allow better comparison between the results of different studies.Keywords
This publication has 21 references indexed in Scilit:
- Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?PLOS ONE, 2008
- Interferon-α promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosisBlood, 2007
- Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapyAnnals Of The Rheumatic Diseases, 2007
- The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosisAnnals Of The Rheumatic Diseases, 2007
- Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosusAnnals Of The Rheumatic Diseases, 2007
- Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosusArthritis Research & Therapy, 2007
- Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosisArthritis Research & Therapy, 2007
- Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patientsAnnals Of The Rheumatic Diseases, 2006
- Depletion of Endothelial Progenitor Cells in the Peripheral Blood of Patients With Rheumatoid ArthritisCirculation, 2005
- Hybrid Cell–Gene Therapy for Pulmonary Hypertension Based on Phagocytosing Action of Endothelial Progenitor CellsCirculation, 2003